Open Access
- 7 November 2026
- journal article
- research article
- Published by Wiley in Pediatric Pulmonology
- Vol. 61 (11) , e71899
Abstract
Background: Published data on cystic fibrosis (CF) among Egyptian people with cystic fibrosis (pwCF) are limited, and most previous reports have been from single centers. This study describes the demographic, clinical, and CFTR variant characteristics of a large multicenter cohort of Egyptian pwCF. Methods: We conducted a multicenter retrospective descriptive cohort study including pwCF treated at seven Egyptian university children's hospitals from 2020 through 2024. Eligible participants had clinical features consistent with CF and positive sweat chloride testing. Demographic, clinical, sweat chloride, and genetic testing data were collected from medical records. All participants underwent limited CFTR variant testing; participants with one or no identified variants were eligible for additional CFTR sequencing when available. Results: A total of 475 Egyptian pwCF were included. Participants were recruited from Cairo University, Ain Shams University, Zagazig University, Mansoura University, Tanta University, Alexandria University, and Assiut University. Among the cohort, 175 participants had two identified CFTR variants, 32 had one identified variant, and 268 had no variant identified on available testing. F508del was the most frequent variant, followed by N1303K. Nine novel CFTR variants were identified. Conclusion: This multicenter retrospective cohort study represents one of the largest reported cohorts of Egyptian pwCF. The findings highlight the genetic heterogeneity of CF in Egypt and support the development of an Egyptian CFTR variant panel, expanded access to comprehensive genetic testing, and broader implementation of newborn screening.Keywords
This publication has 16 references indexed in Scilit:
- Characterization of Egyptian cystic fibrosis children including genotypes and phenotypes: A single tertiary center experienceRespiratory Medicine, 2025
- Elexacaftor-tezacaftor-ivacaftor in people with cystic fibrosis harbouring two CFTR Class I variants: real-world data from the French compassionate programmeeClinicalMedicine, 2025
- A systematic review of the epidemiology of cystic fibrosis in arab countries: An updateClinical Epidemiology and Global Health, 2024
- Distribution of pathogenic variants in the CFTR gene in a representative cohort of people with cystic fibrosis in the Kingdom of BahrainMolecular Genetics and Genomics, 2024
- Updated recommendations for CFTR carrier screening: A position statement of the American College of Medical Genetics and Genomics (ACMG)Genetics in Medicine, 2023
- Worldwide rates of diagnosis and effective treatment for cystic fibrosisJournal of Cystic Fibrosis, 2022
- The Epidemiology of Cystic Fibrosis in Arab Countries: A Systematic ReviewSN Comprehensive Clinical Medicine, 2021
- The future of cystic fibrosis care: a global perspectiveThe Lancet Respiratory Medicine, 2020
- Profile of cystic fibrosis in a single referral center in EgyptJournal of Advanced Research, 2014
- Cystic fibrosis detection in high-risk Egyptian children and CFTR mutation analysisJournal of Cystic Fibrosis, 2007